|
A-050
|
Amine Mixture-6, 250 μg/mL of each component
|
$158.00
|
| |
|
|
B-033
|
Benzodiazepine Multi-Component Mixture-8, 250 μg/mL of each component
|
$179.00
|
| |
|
|
B-041
|
Barbiturate Mix-5, 250 µg/mL of each component
|
$81.00
|
| |
|
|
C-088
|
Cocaine Multi-Component Mixture-4, 250 μg/mL of each component
|
$148.00
|
| |
|
|
C-109
|
Catecholamine Mix 1 (Epinephrines), 1.0 mg/mL (as free base) of each component
|
$105.00
|
| |
|
|
C-110
|
Catecholamine Mix 2 (Metanephrines), 1.0 mg/mL (as free base) of each component
|
$168.00
|
| |
|
|
C-111
|
Catecholamine Metabolites Mix, 1.0 mg/mL of each component
|
$188.00
|
| |
|
|
I-023
|
Interference Mix 1 (For Qualitative Use Only), 100-1000 µg/mL of each component
|
$194.00
|
| |
|
|
I-024
|
Interference Mix 2 (For Qualitative Use Only), 100 µg/mL of each analyte
|
$168.00
|
| |
|
|
I-025
|
Interference Mix 3 (For Qualitative Use Only), 50-1000 µg/mL of each component
|
$200.00
|
| |
|
|
I-026
|
Interference Mix 4 (For Qualitative Use Only), 5-100 µg/mL of each component
|
$227.00
|
| |
|
|
I-027
|
Interference Mix 5, 100 µg/mL of each analyte
|
$273.00
|
| |
|
|
I-028
|
Interference Mix 6, 5-100 µg/mL of each component
|
$263.00
|
| |
|
|
I-029
|
Interference Mix 7 (For Qualitative Use Only), 50-100 µg/mL of each component
|
$184.00
|
| |
|
|
I-030
|
Interference Mix Kit (For Qualitative Use Only),Kit – 7 x1 mL; Kit contains 1 ampoule each of I-023, I-024, I-025, I-026, I-027, I-028, I-029
|
$1,215.00
|
| |
|
|
M-025
|
Methamphetamine/Cocaine/Heroin Mix, 250 μg/mL of each component
|
$81.00
|
| |
|
|
O-020
|
Opiate Multi-Component Mixture-5, 250 μg/mL of each component
|
$120.00
|
| |
|
|
O-034
|
Over-The-Counter Multi-Component Mixture-6, 100 μg/mL of each analyte
|
$184.00
|
| |
|
|
P-071
|
Pain Management Multi-Component Opiate Mixture-13, 100 μg/mL of each component; 10 μg/mL of Fentanyl
|
$324.00
|
| |
|
|
S-038
|
Spice Cannabinoid Mix, 100 µg/mL of each component
|
$270.00
|
| |
|
|
S-041
|
Spice Cannabinoid Mix 2, 100 μg/mL of each component
|
$249.00
|
| |
|